Doug Schenkel
Stock Analyst at Wolfe Research
(2.84)
# 1,610
Out of 5,146 analysts
70
Total ratings
50%
Success rate
32.5%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Upgrades: Outperform | $60 | $39.89 | +50.41% | 3 | Dec 10, 2025 | |
| WAT Waters | Upgrades: Outperform | $480 | $319.44 | +50.26% | 2 | Dec 10, 2025 | |
| GH Guardant Health | Upgrades: Outperform | $75 | $95.27 | -21.28% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $18.31 | +74.77% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $53.71 | +11.71% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $75.34 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $49.58 | +21.02% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $15.30 | +83.01% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $247.88 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $132.14 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $3.26 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $285 | $209.52 | +36.03% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $124.72 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $49 | $48.62 | +0.88% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $19.66 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $121.87 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $103.27 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $513.68 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.78 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $97.57 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.63 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $9.06 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $211.83 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.60 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $2.74 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.29 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.82 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.09 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $24.07 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $1.12 | +1,507.14% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $26.01 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $248.12 | -63.73% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.29 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $152.84 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $73.16 | -78.13% | 2 | Sep 28, 2017 |
Bruker
Dec 10, 2025
Upgrades: Outperform
Price Target: $60
Current: $39.89
Upside: +50.41%
Waters
Dec 10, 2025
Upgrades: Outperform
Price Target: $480
Current: $319.44
Upside: +50.26%
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $95.27
Upside: -21.28%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $18.31
Upside: +74.77%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $53.71
Upside: +11.71%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $75.34
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $49.58
Upside: +21.02%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $15.30
Upside: +83.01%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $247.88
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $132.14
Upside: -
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $3.26
Upside: -
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $209.52
Upside: +36.03%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $124.72
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $49
Current: $48.62
Upside: +0.88%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $19.66
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $121.87
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $103.27
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $513.68
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $4.78
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $97.57
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.63
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $9.06
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $211.83
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.60
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.74
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.29
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.82
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.09
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $24.07
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $1.12
Upside: +1,507.14%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $26.01
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $248.12
Upside: -63.73%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $6.29
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $152.84
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $73.16
Upside: -78.13%